Effects of noradrenaline and dopamine on supraspinal fatigue in well-trained men

Medicine and Science in Sports and Exercise

Volumn 44, Issue 12, 2012, Pages 2299-2308

  Klass, Malgorzata ^a   Roelands, Bart ^b,c   LIvInez, Morgan ^a   Fontenelle, Vinciane ^b   Pattyn, Nathalie ^b   Meeusen, Romain ^b   Duchateau, Jacques ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

Author keywords

Central fatigue; Corticospinal excitability; EMG; Knee extensor muscles; Transcranial magnetic stimulation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; METHYLPHENIDATE; MORPHOLINE DERIVATIVE; NORADRENALIN; REBOXETINE;

ADULT; ARTICLE; ATHLETIC PERFORMANCE; BICYCLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FITNESS; HUMAN; MALE; METABOLISM; MOTOR CORTEX; MUSCLE CONTRACTION; MUSCLE FATIGUE; NEUROFEEDBACK; PHYSIOLOGY; PYRAMIDAL TRACT; RANDOMIZED CONTROLLED TRIAL; TRANSCRANIAL MAGNETIC STIMULATION;

ADRENERGIC ALPHA-AGONISTS; ADULT; ATHLETIC PERFORMANCE; BICYCLING; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; HUMANS; MALE; METHYLPHENIDATE; MORPHOLINES; MOTOR CORTEX; MUSCLE CONTRACTION; MUSCLE FATIGUE; NEUROFEEDBACK; NOREPINEPHRINE; PHYSICAL FITNESS; PYRAMIDAL TRACTS; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 84870061927     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e318265f356     Document Type: Article

References (42)

1. Amann M, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans. J Physiol. 2009;587(Pt 1):271-83.
2. Benarroch EE. The locus ceruleus norepinephrine system: functional organization and potential clinical significance. Neurology. 2009;73(20):1699-704.
3. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev. 2003;42(1):33-84.
4. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.
5. Davies CT, Young K. Effect of temperature on the contractile properties and muscle power of triceps surae in humans. J Appl Physiol. 1983;55(1 Pt 1):191-5. (Pubitemid 13075339)
6. Davis JM, Bailey SP. Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc. 1997;29(1):45-57.
7. Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2011;69(12):e145-e57.
8. Dinges DF, Powell JW. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods. 1985;17(6):652-5.
9. Gandevia SC, Allen GM, Butler JE, Taylor JL. Supraspinal factors in human muscle fatigue: evidence for suboptimal output from the motor cortex. J Physiol. 1996;490(Pt 2):529-36.
10. Garner SH, Hicks AL, McComas AJ. Prolongation of twitch potentiating mechanism throughout muscle fatigue and recovery. Exp Neurol. 1989;103(3):277-81.
11. Goodall S, Romer LM, Ross EZ. Voluntary activation of human knee extensors measured using transcranial magnetic stimulation. Exp Physiol. 2009;94(9):995-1004.
12. Heyes MP, Garnett ES, Coates G. Central dopaminergic activity influences rats ability to exercise. Life Sci. 1985;36:671-7. (Pubitemid 15159774)
13. Inghilleri M, Berardelli A, Cruccu G, Manfredi M. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol. 1993;466:521-34.
14. Jeukendrup A, Saris WH, Brouns F, Kester AD. A new validated endurance performance test. Med Sci Sports Exerc. 1996;28(2): 266-70.
15. Keller ML, Pruse J, Yoon T, Schlinder-Delap B, Harkins A, Hunter SK. Supraspinal fatigue is similar in men and women for a low-force fatiguing contraction. Med Sci Sports Exerc. 2011; 43(10):1873-83.
16. Kerr JS, Powell J, Hindmarch I. The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Pharmacol. 1996;42(2): 239-41.
17. Klass M, Lévénez M, Enoka RM, Duchateau J. Spinal mechanisms contribute to differences in the time to failure of submaximal fatiguing contractions performed with different loads. J Neurophysiol. 2008;99(3):1096-104.
18. Kremenic IJ, Glace BW, Ben-Avi SS, Nicholas SJ, McHugh MP. Central fatigue after cycling evaluated using peripheral magnetic stimulation. Med Sci Sports Exerc. 2009;41(7):1461-6.
19. Lee S-B, Beak SK, Park SH, Waterhouse BD, Lee HS. Collateral projection from the locus coeruleus to whisker-related sensory and motor brain regions of the rat. J Comp Neurol. 2009;514(4): 387-402.
20. Lepers R, Maffiuletti NA, Rochette L, Brugniaux J, Millet GY. Neuromuscular fatigue during a long-duration cycling exercise. J Appl Physiol. 2002;92(4):1487-93.
21. Lévénez M, Garland SJ, Klass M, Duchateau J. Cortical and spinal modulation of antagonist coactivation during a submaximal fatiguing contraction in humans. J Neurophysiol. 2008;99(2):554-63.
22. Lim J, Wu W-C, Wang J, Detre JA, Dinges DF, Rao H. Imaging brain fatigue from sustained mental workload: an ASL perfusion study of the time-on-Task effect. Neuroimage. 2010;49(4):3426-35.
23. Linnér L, Endersz H, Ohman D, Bengtsson F, Schalling M, Svensson TH. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J Pharmacol Exp Ther. 2001;297(2):540-6. (Pubitemid 32377983)
24. Mackworth JF. Vigilance, arousal, and habituation. Psychol Rev. 1968;75(4):308-22.
25. Meeusen R, Watson P, Hasegawa H, Roelands B, Piacentini MF. Central fatigue: the serotonin hypothesis and beyond. Sports Med. 2006;36(10):881-909.
26. Miller DK, Wong EHF, Chesnut MD, Dwoskin LP. Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 2002;302(2):687-95.
27. Millet GY, Lepers R. Alterations of neuromuscular function after prolonged running, cycling and skiing exercises. Sports Med. 2004;34(2):105-16.
28. Millet GY, Millet GP, Lattier G, Maffiuletti NA, Candau R. Alteration of neuromuscular function after a prolonged road cycling race. Int J Sports Med. 2003;24(3):190-4. (Pubitemid 36606405)
29. Newsholme EA. Amino acids, brain neurotransmitters and a function link between muscle and brain that is important in sustained exercise. In: Benzi G, editor. Advances in Myochemistry. London: John Libbey Eurotext; 1987. pp. 127-33.
30. Nybo L. CNS fatigue provoked by prolonged exercise in the heat. Front Biosci. 2010;2:779-92.
31. Pietrzak RH, Mollica CM, Maruff P, Snyder PJ. Cognitive effects of immediate-release methylphenidate in children with attentiondeficit/ hyperactivity disorder. Neurosci Biobehav Rev. 2006;30(8): 1225-45.
32. Roelands B, Goekint M, Buyse L, et al. Time trial performance in normal and high ambient temperature: is there a role for 5-HT? Eur J Appl Physiol. 2009;107(1):119-26.
33. Roelands B, Goekint M, Heyman E, et al. Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperature. J Appl Physiol. 2008;105(1):206-12.
34. Roelands B, Hasegawa H, Watson P, et al. The effects of acute dopamine reuptake inhibition on performance. Med Sci Sports Exerc. 2008;40(5):879-85.
35. Roelands B, Meeusen R. Alterations in central fatigue by pharmacological manipulations of neurotransmitters in normal and high ambient temperature. Sports Med. 2010;40(3):229-46.
36. Sidhu SK, Bentley DJ, Carroll TJ. Locomotor exercise induces long-lasting impairments in the capacity of the human motor cortex to voluntarily activate knee extensor muscles. J Appl Physiol. 2009;106(2):556-65.
37. SLgaard K, Gandevia SC, Todd G, Petersen NT, Taylor JL. The effect of sustained low-intensity contractions on supraspinal fatigue in human elbow flexor muscles. J Physiol. 2006;573(Pt 2):511-23.
38. Taylor JL, Todd G, Gandevia SC. Evidence for a supraspinal contribution to human muscle fatigue. Clin Exp Pharmacol Physiol. 2006;33(4):400-5.
39. Theunissen EL, Elvira Jde L, van den Bergh D, Ramaekers JG. Comparing the stimulant effects of the H1-Antagonist fexofenadine with 2 psychostimulants, modafinil and methylphenidate. J Clin Psychopharmacol. 2009;29(5):439-43.
40. Todd G, Taylor JL, Gandevia SC. Measurement of voluntary activation of fresh and fatigued human muscles using transcranial magnetic stimulation. J Physiol. 2003;551(Pt 2):661-71.
41. Waterhouse BD, Moises HC, Woodward DJ. Noradrenergic modulation of somatosensory cortical neuronal responses to iontophoretically applied putative neurotransmitters. Exp Neurol. 1980;69(1):30-49.
42. Waterhouse BD, Woodward DJ. Interaction of norepinephrine with cerebrocortical activity evoked by stimulation of somatosensory afferent pathways in the rat. Exp Neurol. 1980;67(1):11-34.